SCHEMBL148703

SCHEMBL148703

CCOC(=O)c1ccc2c(c1)[nH]c1c(C#N)ccc(Br)c12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 2/20 0.46
SIRT2 Q8IXJ6 1/20 0.44
ALDH1A1 P00352 5/20 0.43
MAPT P10636 5/20 0.43
KDM4E B2RXH2 4/20 0.43
RAB9A P51151 3/20 0.43
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
HSD17B10 Q99714 3/20 0.42
MAPK1 P28482 3/20 0.42
POLB P06746 2/20 0.42
HPGD P15428 1/20 0.42
NPC1 O15118 1/20 0.42
ALOX15 P16050 2/20 0.41
IMPDH2 P12268 1/20 0.40
PPARG P37231 1/20 0.40
NCOA2 Q15596 1/20 0.40
NCOA1 Q15788 1/20 0.40
L3MBTL1 Q9Y468 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9984988 0.82 GABRA1 (0.45) ALDH1A1MAPTKDM4EMEN1KMT2A
SCHEMBL150341 0.81 HCRTR1 (0.47) HCRTR1SIRT2ALDH1A1MAPTKDM4E
SCHEMBL2421850 0.77 CA12 (0.51) HCRTR1ALDH1A1MAPTKDM4ERAB9A
SCHEMBL28457805 0.75 ALDH1A1 (0.44) ALDH1A1MAPTKDM4ERAB9AMEN1
SCHEMBL13387012 0.74 IMPDH2 (0.58) HCRTR1ALDH1A1MAPTKDM4ERAB9A
SCHEMBL6007665 0.74 ALDH1A1 (0.70) HCRTR1SIRT2ALDH1A1MAPTKDM4E
SCHEMBL16333578 0.72 SIRT2 (0.45) HCRTR1SIRT2ALDH1A1MAPTKDM4E
SCHEMBL15994245 0.72 SIRT2 (0.43) HCRTR1SIRT2ALDH1A1MAPTKDM4E
SCHEMBL2474590 0.72 CA12 (0.51) HCRTR1ALDH1A1MAPTKDM4ERAB9A
SCHEMBL12398077 0.72 HCRTR1 (0.78) HCRTR1SIRT2ALDH1A1MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2391602-B1 CARBAZOLE CARBOXAMIDE COMPOUNDS USEFUL AS KINASE INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2013-12-04 EP disclosed
US-8362065-B2 Carbazole carboxamide compounds useful as kinase inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2013-01-29 US disclosed
US-20120058996-A1 CARBAZOLE CARBOXAMIDE COMPOUNDS USEFUL AS KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY 2012-03-08 US disclosed
US-8084620-B2 Carbazole carboxamide compounds useful as kinase inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2011-12-27 US disclosed
EP-2391602-A1 CARBAZOLE CARBOXAMIDE COMPOUNDS USEFUL AS KINASE INHIBITORS Bristol-Myers Squibb Company (US) 2011-12-07 EP disclosed
WO-2010080481-A1 CARBAZOLE CARBOXAMIDE COMPOUNDS USEFUL AS KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2010-07-15 WO disclosed
US-20100160303-A1 CARBAZOLE CARBOXAMIDE COMPOUNDS USEFUL AS KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY 2010-06-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120058996-A1 CARBAZOLE CARBOXAMIDE COMPOUNDS USEFUL AS KINASE INHIBITORS BTK, FLT3, JAK1 HCRTR1 1981/4885SIRT2 736/4885ALDH1A1 3832/4885
US-20100160303-A1 CARBAZOLE CARBOXAMIDE COMPOUNDS USEFUL AS KINASE INHIBITORS BTK, FLT3, JAK1 HCRTR1 1981/4885SIRT2 736/4885ALDH1A1 3832/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.